Literature DB >> 14531952

Antigen-specific T cells in rheumatoid arthritis.

Sean R Bennett1, Michael T Falta, Jerry Bill, Brian L Kotzin.   

Abstract

There is considerable evidence of a key role for CD4+ T cells in the pathogenesis of rheumatoid arthritis. Several attractive candidate antigens, mostly joint-specific, have been studied, but information regarding T cell responses to these antigens in patients is limited and occasionally contradictory. Novel reagents (such as major histocompatibility complex and peptide tetramers) and sensitive techniques (such as intracellular cytokine staining) will aid in future studies to identify antigen-specific T cells. In addition, a new animal model of inflammatory arthritis has recently provided new perspective to the study of rheumatoid arthritis by drawing attention to systemic self-antigens as targets of autoimmunity and anti-self antibodies as markers of T cell activity and effectors of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531952     DOI: 10.1007/s11926-003-0003-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  53 in total

1.  Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4.

Authors:  E Boen; A R Crownover; M McIlhaney; A J Korman; J Bill
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 2.  Autoimmune disease: why and where it occurs.

Authors:  P Marrack; J Kappler; B L Kotzin
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

3.  Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease.

Authors:  M Schaller; D R Burton; H J Ditzel
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.

Authors:  A P Cope; S D Patel; F Hall; M Congia; H A Hubers; G F Verheijden; A M Boots; R Menon; M Trucco; A W Rijnders; G Sønderstrup
Journal:  Arthritis Rheum       Date:  1999-07

Review 5.  CD4+ T-cell subsets in autoimmunity.

Authors:  A O'Garra; L Steinman; K Gijbels
Journal:  Curr Opin Immunol       Date:  1997-12       Impact factor: 7.486

6.  Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes.

Authors:  Y Zhang; A Guerassimov; J Y Leroux; A Cartman; C Webber; R Lalic; E de Miguel; L C Rosenberg; A R Poole
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  p205 is a major target of autoreactive T cells in rheumatoid arthritis.

Authors:  S Bläss; F Schumann; N A Hain; J M Engel; B Stuhlmüller; G R Burmester
Journal:  Arthritis Rheum       Date:  1999-05

8.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

9.  Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.

Authors:  J Zou; Y Zhang; A Thiel; M Rudwaleit; S-L Shi; A Radbruch; R Poole; J Braun; J Sieper
Journal:  Rheumatology (Oxford)       Date:  2003-02-28       Impact factor: 7.580

10.  Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Authors:  David M Lee; Daniel S Friend; Michael F Gurish; Christophe Benoist; Diane Mathis; Michael B Brenner
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

View more
  6 in total

Review 1.  Biological therapies directed against cells in autoimmune disease.

Authors:  Paul Hasler
Journal:  Springer Semin Immunopathol       Date:  2006-04-28

2.  Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

Authors:  Marije I Koenders; Erik Lubberts; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Monique M Helsen; Franco E Di Padova; Annemieke M H Boots; Hermann Gram; Leo A B Joosten; Wim B van den Berg
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  The degree of CD4+ T cell autoreactivity determines cellular pathways underlying inflammatory arthritis.

Authors:  Olivia A Perng; Malinda Aitken; Andrew L Rankin; Victoria Garcia; Elizabeth Kropf; Jan Erikson; David S Garlick; Andrew J Caton
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

4.  Annexin-1 modulates T-cell activation and differentiation.

Authors:  Fulvio D'Acquisto; Ahmed Merghani; Emilio Lecona; Guglielmo Rosignoli; Karim Raza; Christopher D Buckley; Roderick J Flower; Mauro Perretti
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 5.  The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.

Authors:  Thomas Kamradt; David Schubert
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

Review 6.  The virus-immunity ecosystem.

Authors:  P C Doherty; S J Turner
Journal:  Arch Virol Suppl       Date:  2005
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.